Open | - |
Close | - |
Volume / Avg. | 0 / 37.501K |
Day Range | - - - |
52 Wk Range | 2.080 - 4.000 |
Market Cap | $123.335M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 58 |
Short Interest | 0.08% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Genetron Holdings (NASDAQ: GTH) through any online brokerage.
Other companies in Genetron Holdings’s space includes: Vincerx Pharma (NASDAQ:VINC), Molecular Partners (NASDAQ:MOLN), Zura Bio (NASDAQ:ZURA), Anixa Biosciences (NASDAQ:ANIX) and Galectin Therapeutics (NASDAQ:GALT).
The latest price target for Genetron Holdings (NASDAQ: GTH) was reported by BTIG on Thursday, April 21, 2022. The analyst firm set a price target for 10.00 expecting GTH to rise to within 12 months (a possible 156.41% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Genetron Holdings (NASDAQ: GTH) is $3.9 last updated March 13, 2024 at 4:28 AM EDT.
There are no upcoming dividends for Genetron Holdings.
Genetron Holdings’s Q3 earnings are confirmed for Monday, April 1, 2024.
There is no upcoming split for Genetron Holdings.
Genetron Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.